Trust Company’s IDEAYA Biosciences IDYA Stock Holding History

Trust Company’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$768	Hold	20	–	–	﹤0.01%	653
2026 Q2	$745	Hold	20	–	–	﹤0.01%	656
2026 Q1	$666	Hold	20	–	–	﹤0.01%	643
2025 Q4	$691	Buy	+20	New	+$638	﹤0.01%	606

Other funds holding IDYA

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

General American Investors New York $1.71B AUM 30.1% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.39% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Trust Company's IDYA Position: Q3 2026 in Review

Trust Company held its IDEAYA Biosciences (IDYA) position steady in Q3 2026 at 20 shares worth $768. The position accounts for ﹤0.01% of the portfolio, ranked #653.

Trust Company first reported a position in IDYA in Q4 2025 and has held it in 4 quarters since. 84 funds tracked by Wall St. Rank hold IDYA as of Q3 2026.

Trust Company held 20 shares of IDEAYA Biosciences worth $768 as of Q3 2026.
Trust Company left its IDEAYA Biosciences share count unchanged in Q3 2026.
IDEAYA Biosciences made up ﹤0.01% of Trust Company's portfolio in Q3 2026, its #653 holding.
Trust Company first reported a position in IDEAYA Biosciences in Q4 2025 and has held it in 4 quarters since.
84 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2026.

Based on Trust Company's 13F filing for Q3 2026, filed 9 Oct 2026.